Results 161 to 170 of about 29,201 (203)

Neoadjuvant therapy in skin cancer: current evidence and future perspectives. [PDF]

J Dtsch Dermatol Ges
Daniello L, Kleemann J, Schilling B.
europepmc   +1 more source

MicroRNAs as Diagnostic and Prognostic Biomarkers in Melanoma and Non-Melanoma Skin Cancers: An Updated Review. [PDF]

Diagnostics (Basel)
Oiegar A, Tigu AB, Baican A, Candrea E, Negrutiu M, Danescu S.   +5 more
europepmc   +1 more source

Merkel cell carcinoma immunotherapy: key questions in the era of immune checkpoint blockade. [PDF]

J Immunother Cancer
Becker JC, Lodde G, Haist M, Ugurel S.
europepmc   +1 more source

Merkel cell carcinoma in solid organ transplant recipients: prognosis and response to immunotherapy. [PDF]

Br J Dermatol
Akaike T, Ch'en PY, Hippe DS, Gilmour MW, Gong E, Fu A, Singh N, Cahill K, Gunnell L, Vohra N, Hall E, Bhatia S, Lipson EJ, Blosser CD, Nghiem P.   +14 more
europepmc   +1 more source

Long-term immune checkpoint inhibition therapy for advanced stage Merkel cell carcinoma. [PDF]

JAAD Case Rep
Diiorio MR, Trepanowski N, Shah P, Shirai K.   +3 more
europepmc   +1 more source

Late Metastatic Recurrence of Merkel Cell Carcinoma Nine Years After the Primary Diagnosis. [PDF]

Cureus
Kubicki SL, Forbes Kaprive J, Kwong A, Rivlin D, Emerson CM.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Merkel Cell Carcinoma

The Laryngoscope, 2004
AbstractPurpose: To determine the natural history and treatment outcomes for patients with Merkel cell carcinoma.Methods: Review of the literature.Results: The probability of regional node involvement at presentation exceeds 50%; few patients present with distant metastases.
William M, Mendenhall, Charles M, Mendenhall, Nancy Price, Mendenhall   +2 more
openaire   +4 more sources